Current Opinion in Infectious Diseases: Editorial

Current Opinion in Infectious Diseases

Volumn 24, Issue 2, 2011, Pages 95-96

  Finch, Roger G ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEMASE; ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; ASPERGILLOSIS; BLOODSTREAM INFECTION; CANDIDIASIS; CLINICAL PRACTICE; EDITORIAL; GRAM POSITIVE INFECTION; HEALTH CARE PERSONNEL; HEPATITIS C VIRUS; HERPES VIRUS INFECTION; HOSPITAL MANAGEMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFLUENZA VIRUS; MALARIA; PSEUDOMONAS INFECTION; STAPHYLOCOCCUS AUREUS; ANTIBIOTIC RESISTANCE; ECONOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; DELIVERY OF HEALTH CARE; DRUG RESISTANCE, MICROBIAL; HEALTH CARE COSTS; HUMANS; INFECTION;

EID: 79952184825     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32834448d7     Document Type: Editorial

References (11)

1. Finch RG. Antimicrobial agents: bacterial/fungal-overview. Curr Opin Infect Dis 1988; 1:339-341.
2. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological and epidemiological study. Lancet Infect Dis 2010; 10:597-602.
3. Talbot GH, Bradley J, Edwards JE, et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Task Force of the Infectious Diseases Soc (Pubitemid 43271379)
4. Finch R, Hunter PA. Antibiotic resistance: action to promote new technologies-report of an EU intergovernmental conference held in Birmingham, UK, 12-13 December 2005. J Antimicrob Chemother 2006; 58:i3-i22. (Pubitemid 44605585)
5. Tickell S. The Antibiotic Innovation Study: expert voices on a critical need. ReACT, Action on Antibiotic Resistance; 2005. http://soapimg.icecube. snowfall.se/stopresistance/Innovation-report.pdf (accessed 25 January 2011).
6. Finch RG. Generic antibiotics, antibiotic resistance, and drug licensing. Lancet Infect Dis 2010; 10:754.
7. The Health & Social Care Act (2008). http://www.dh.gov.uk/en/ Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH-122604 (accessed 25 January 2011).
8. Finch RG. Innovation: drugs and diagnostics. J Antimicrob Chemother 2007; 60 (Suppl 1):i79-i82.
9. Platts P, Manson PG, Finch RG. Acute pharyngitis: a symptom scorecard and microbiological assessment. Br Med J 1982; 284:387-388.
10. Little P. Delayed prescribing of antibiotics for upper respiratory tract infections. Br Med J 2005; 331:301-302. (Pubitemid 41113135)
11. Lambert M-L, Suetens C, Savey A, et al. Clinical outcomes of health-careassociated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011; 11:30-38.